drugset
drugset / Trial / NCT02777008

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects

NCT02777008 ↗

Phase 1 Completed 77 enrolled Concert Pharmaceuticals
RandomizedParallel-groupTriple-blindBasic science

Summary

Single- and multiple-ascending dose study of CTP-543 in healthy volunteers.

Timeline

Start
2016-05
Primary completion
2016-12
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject CTP-543 Unknown — Oral

Indications

No indication recorded.